Health
AstraZeneca vaccine trial hold leaves US participants in limbo – STAT
Experts say there’s no need to worry about this group or their data, because such trials are designed to account for such situations.
For the 20-something-year-old Hispanic man, volunteering for AstraZenecas Phase 3 Covid-19 vaccine study was an easy decision. His father, after all, had been briefly hospitalized with Covid-19, and, even beyond that personal motivation, signing up was the right thing to do, he told STAT.
The clinical trial participant, who lives in the western U.S., got his first shot in early September he doesnt know if he got the actual vaccine or a saline placebo, in line with the studys double-blinded desi…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News22 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
General20 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat